EUS-guided Intratumoral Gemcitabine in Locally Advanced Unresectable Pancreatic Cancer

NCT01834170 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

DRUG: Gemcitabine

Sponsor

University of Tehran